Pulmonary Mycobacterium kyorinense disease: A case report and review of literature
dc.contributor.author | Saranathan, R | en_US |
dc.contributor.author | Padmapriyadarsini, C | en_US |
dc.contributor.author | Sivaramakrishnan, GN | en_US |
dc.contributor.author | Perumal, BK | en_US |
dc.contributor.author | Kannayan, S | en_US |
dc.contributor.author | Joseph, B | en_US |
dc.contributor.author | Gopalan, N | en_US |
dc.contributor.author | Hanna, LE | en_US |
dc.date.accessioned | 2020-04-23T07:37:47Z | |
dc.date.available | 2020-04-23T07:37:47Z | |
dc.date.issued | 2019-03 | |
dc.description.abstract | We report here the first case of pulmonary infection due to Mycobacterium kyorinense in a 55-year-old hypertensive woman treated for pulmonary tuberculosis earlier on two occasions. She presented with productive cough, intermittent episode of left-sided chest pain, loss of appetite, low-grade fever, and breathlessness. Sputum cultures revealed non-tuberculous mycobacteria (NTM). She remained persistently symptomatic with sputum cultures positive for acid-fast bacilli even after 6 months of treatment. Hence, a 16SrRNA gene amplification and sequencing were done that revealed M. kyorinense. Based on the guidelines of the American Thoracic Society, she was started on weight-based dosing of clarithromycin, levofloxacin, ethambutol, isoniazid and injection amikacin daily. The patient improved symptomatically and became culture-negative after 3 months of therapy with the above regimen and continued to be culture negative for 12 months of treatment. She continues to remain symptom-free without evidence of any clinical or bacteriological relapse. | en_US |
dc.identifier.affiliations | Department of HIV, ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India | en_US |
dc.identifier.affiliations | Department of Clinical Research, ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India | en_US |
dc.identifier.affiliations | Department of Bacteriology, ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India | en_US |
dc.identifier.citation | Saranathan R, Padmapriyadarsini C, Sivaramakrishnan GN, Perumal BK, Kannayan S, Joseph B, Gopalan N, Hanna LE. Pulmonary Mycobacterium kyorinense disease: A case report and review of literature. Indian Journal of Medical Microbiology. 2019 Mar; 37(1): 127-131 | en_US |
dc.identifier.issn | 0255-0857 | |
dc.identifier.issn | 1998-3646 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/198852 | |
dc.language | en | en_US |
dc.publisher | Indian Association of Medical Microbiologists | en_US |
dc.relation.issuenumber | 1 | en_US |
dc.relation.volume | 37 | en_US |
dc.source.uri | https://dx.doi.org/10.4103/ijmm.IJMM_19_94 | en_US |
dc.subject | 16SrRNA | en_US |
dc.subject | non-tuberculous mycobacteria | en_US |
dc.subject | rifampicin resistance | en_US |
dc.title | Pulmonary Mycobacterium kyorinense disease: A case report and review of literature | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1